Soko Setoguchi Iwata, MD
Internal Medicine · New Brunswick, NJNPI 1336583061
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $14,842 of the $15,511 with a category attached, or 95.7%. 4 manufacturers reported payments, led by Merck at 43.8% of the total. Among internal medicine clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $1292.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$7K
- E.r. Squibb & Sons, L.L.C.$4K
- Regeneron$4K
- Pfizer$669
Across 32 payments — averaging $16,657 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$532K
- Regeneron$1K
What the payments were for
- Consulting fees$14,84296%
- Speaking & faculty fees$6204%
- Food & beverage$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 5 | $6,800 |
| E.r. Squibb & Sons, L.L.C. | 1 | $4,493 |
| Regeneron | 4 | $3,549 |
| Pfizer | 2 | $669 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- XELJANZ$620
How this compares
$15,511 in reported general payments places this provider in the 95th percentile of 4,032 internal medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in New Brunswick
- Stephen MarcellaNew Brunswick$331K
- Steven PeskinNew Brunswick$99K
- James CoromilasNew Brunswick$32K
- Jeffrey CarsonNew Brunswick$31K
- David KountzNew Brunswick$23K
- David ShulkinMorristown$1.7M
- Howard UdermanLakewood$955K
- Darshi SunderamEast Orange$530K
- Annika DrongeEmerson$401K
- Viju VijaysadanKinnelon$325K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.